Norbrook Appoints Global Portfolio Manager
Thursday 10 January 2019
Norbrook has appointed Peter Willis as Global Portfolio Manager. This role will see Peter leading the strategic direction and implementation of both the current and new product portfolio strategies.
This role will focus primarily on optimising the current portfolio and managing the new product development strategy, coordinating cross-functionally with particular focus on commercial & R&D input into the new product launch pipeline.
Peter brings 30 years of sales, marketing & general management experience in the Animal Health and Human pharmaceutical sectors in companies including Novartis (International Product Manager), Astra Zeneca (Global Brand Director), Mundipharma International (Director of European Product Management), Merck Serono (Global Head of Marketing & Sales Excellence). Most recently, he held the role of Executive Director US Commercial Operations in Boehringer Ingelheim Animal Health and was based in Kansas City, USA.
Richard Palmer, Global Head of Sales & Marketing, Norbrook said, “We are delighted to welcome Peter to the team. Along with broad leadership experience, he brings significant commercial and strategic experience from a variety of pharmaceutical sectors.
Peter has a great set of skills to ensure that our ambitious growth plans are successful and we look forward to him also helping us identify further growth opportunities to enhance our NPD pipeline. This appointment underlines Norbrook’s commitment to a strong future for our business and our customers.
Peter Willis added, “I am really looking forward to joining Norbrook. It is a great business with a great reputation. I look forward to working with the Norbrook team to review, evolve and enhance the current and new product portfolio, through a strong, market-focused strategy.”